Abeona Therapeutics (ABEO) Interest Income - Net (2021 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Interest Income - Net of -$3000.0 for Q1 2026, up 94.44% year-over-year from -$1542.9 in Q1 2025, and down 100.09% quarter-over-quarter from $3.4 million in Q4 2025.
Powered by 
Analysis
Abeona Therapeutics (ABEO) Interest Income - Net (2021 - 2026) Analysis & Trends
Abeona Therapeutics' Interest Income - Net history runs 6 years deep, the most recent figure standing at -$3000.0 for Q1 2026.
- In Q1 2026, Interest Income - Net rose 94.44% year-over-year to -$3000.0; the TTM figure through Mar 2026 stood at $3.3 million (up 167.44% YoY), while the FY2025 annual figure was -$69.4 million, down 182642.11% from the prior year.
- Interest Income - Net for Q1 2026 stood at -$3000.0, down from $3.4 million in the prior quarter.
- The five-year high for Interest Income - Net was $3.4 million in Q4 2025, with the low at -$11.5 million in Q1 2022.
- The 5-year median for Interest Income - Net is -$374000.0 (2023), against an average of -$2.1 million.
- The sharpest annual moves came in 2024 and 2025: Interest Income - Net tumbled 444.14% in 2024, then surged 5867.8% in 2025.
- Abeona Therapeutics' Interest Income - Net stood at $150000.0 in 2022, then jumped by 322.67% to $634000.0 in 2023, then slumped by 109.31% to -$59000.0 in 2024, then soared by 5867.8% to $3.4 million in 2025, then plunged by 100.09% to -$3000.0 in 2026.
- Business Quant data shows ABEO's Interest Income - Net at -$3000.0 in Q1 2026, $3.4 million in Q4 2025, and $245000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Abeona Therapeutics | 339.72 Mn | 192.90 Mn | 7.20 Mn | 659,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 659,000.00 |
| Mar 31, 2026 | 524,000.00 |
| Dec 31, 2025 | 663,000.00 |
| Sep 30, 2025 | 771,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Mar 31, 2025 | 312,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Dec 31, 2023 | 634,000.00 |
| Sep 30, 2023 | 488,000.00 |
| Jun 30, 2023 | 314,000.00 |
| Mar 31, 2023 | 263,000.00 |
| Dec 31, 2022 | 150,000.00 |
| Sep 30, 2022 | -85,000.00 |
| Jun 30, 2022 | -169,000.00 |
| Mar 31, 2022 | -194,000.00 |
| Dec 31, 2021 | -48,000.00 |
| Sep 30, 2021 | -676,000.00 |